HighMark Wealth Management »

Organogenesis Hldgs shares owned by HighMark Wealth Management

Quarter-by-quarter ownership of Organogenesis Hldgs (ORGO) shares owned by HighMark Wealth Management from 13F filings

Historical chart of HighMark Wealth Management investment in Organogenesis Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Organogenesis Hldgs held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Organogenesis Hldgs by HighMark Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 293k 4.22
2025-06-30 $1.1M 293k 3.66

More positions owned by HighMark Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Us Vlu (IUSV)
Wells Fargo & Company (WFC)
Performant Finl (PHLT)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Anaptysbio Inc Common (ANAB)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Ishares Tr Core S&p Mcp Etf (IJH)
Axogen (AXGN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Neogenomics Com New (NEO)

View all positions for HighMark Wealth Management

Top funds holding Organogenesis Hldgs

Soleus Capital Management
Morgan Stanley
First Light Asset Management
Vanguard Group
Assenagon Asset Management
BlackRock
Deutsche Bank Aktiengesellschaft
Dimensional Fund Advisors
Acadian Asset Management
Geode Capital Management
State Street Corporation
Charles Schwab Investment Management
Renaissance Technologies
AQR Capital Management
Northern Trust

View all funds holding Organogenesis Hldgs